Purchases and Sales Made in Q3 2024 in Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV) during Q3 2024. The information is specifically focused on institutions that hold shares of Elevation Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-322K- 25.32% |
$181K - $974K
|
951K
$552K
|
|
|
Nov 14, 2024
Q3 2024
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-502K- 27.89% |
$281K - $1.52M
|
1.3M
$753K
|
|
|
Nov 13, 2024
Q3 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-1.04M- 43.31% |
$582K - $3.14M
|
1.36M
$788K
|
|
|
Nov 14, 2024
Q3 2024
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-2M- 80.89% |
$1.12M - $6.05M
|
474K
$275K
|